Genetic modification of stem cells for transplantation

M. Ian Phillips, Yao Liang Tang

Research output: Contribution to journalReview article

41 Citations (Scopus)

Abstract

Gene modification of cells prior to their transplantation, especially stem cells, enhances their survival and increases their function in cell therapy. Like the Trojan horse, the gene-modified cell has to gain entrance inside the host's walls and survive and deliver its transgene products Using cellular, molecular and gene manipulation techniques the transplanted cell can be protected in a hostile environment from immune rejection, inflammation, hypoxia and apoptosis. Genetic engineering to modify cells involves constructing modules of functional gene sequences. They can be simple reporter genes or complex cassettes with gene switches, cell specific promoters and multiple transgenes. We discuss methods to deliver and construct gene cassettes with viral and non-viral delivery, siRNA, and conditional Cre/Lox P. We review the current uses of gene-modified stem cells in cardiovascular disease, diabetes, neurological diseases, (including Parkinson's, Alzheimer's and spinal cord injury repair), bone defects, hemophilia, and cancer.

Original languageEnglish (US)
Pages (from-to)160-172
Number of pages13
JournalAdvanced Drug Delivery Reviews
Volume60
Issue number2
DOIs
StatePublished - Jan 14 2008

Fingerprint

Stem Cell Transplantation
Genes
Transgenes
Spinal Cord Regeneration
Switch Genes
Genetic Engineering
Gene Regulatory Networks
Hemophilia A
Cell- and Tissue-Based Therapy
Spinal Cord Injuries
Reporter Genes
Small Interfering RNA
Parkinson Disease
Cardiovascular Diseases
Stem Cells
Apoptosis
Inflammation
Bone and Bones
Neoplasms

Keywords

  • Cancer
  • Cre/Lox P
  • Diabetes
  • Heart failure
  • MicroRNA
  • Neurological diseases
  • Stem cells
  • Vigilant Vector

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Genetic modification of stem cells for transplantation. / Phillips, M. Ian; Tang, Yao Liang.

In: Advanced Drug Delivery Reviews, Vol. 60, No. 2, 14.01.2008, p. 160-172.

Research output: Contribution to journalReview article

@article{f76987f11ca34bcca243891833976d0a,
title = "Genetic modification of stem cells for transplantation",
abstract = "Gene modification of cells prior to their transplantation, especially stem cells, enhances their survival and increases their function in cell therapy. Like the Trojan horse, the gene-modified cell has to gain entrance inside the host's walls and survive and deliver its transgene products Using cellular, molecular and gene manipulation techniques the transplanted cell can be protected in a hostile environment from immune rejection, inflammation, hypoxia and apoptosis. Genetic engineering to modify cells involves constructing modules of functional gene sequences. They can be simple reporter genes or complex cassettes with gene switches, cell specific promoters and multiple transgenes. We discuss methods to deliver and construct gene cassettes with viral and non-viral delivery, siRNA, and conditional Cre/Lox P. We review the current uses of gene-modified stem cells in cardiovascular disease, diabetes, neurological diseases, (including Parkinson's, Alzheimer's and spinal cord injury repair), bone defects, hemophilia, and cancer.",
keywords = "Cancer, Cre/Lox P, Diabetes, Heart failure, MicroRNA, Neurological diseases, Stem cells, Vigilant Vector",
author = "Phillips, {M. Ian} and Tang, {Yao Liang}",
year = "2008",
month = "1",
day = "14",
doi = "10.1016/j.addr.2007.08.035",
language = "English (US)",
volume = "60",
pages = "160--172",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Genetic modification of stem cells for transplantation

AU - Phillips, M. Ian

AU - Tang, Yao Liang

PY - 2008/1/14

Y1 - 2008/1/14

N2 - Gene modification of cells prior to their transplantation, especially stem cells, enhances their survival and increases their function in cell therapy. Like the Trojan horse, the gene-modified cell has to gain entrance inside the host's walls and survive and deliver its transgene products Using cellular, molecular and gene manipulation techniques the transplanted cell can be protected in a hostile environment from immune rejection, inflammation, hypoxia and apoptosis. Genetic engineering to modify cells involves constructing modules of functional gene sequences. They can be simple reporter genes or complex cassettes with gene switches, cell specific promoters and multiple transgenes. We discuss methods to deliver and construct gene cassettes with viral and non-viral delivery, siRNA, and conditional Cre/Lox P. We review the current uses of gene-modified stem cells in cardiovascular disease, diabetes, neurological diseases, (including Parkinson's, Alzheimer's and spinal cord injury repair), bone defects, hemophilia, and cancer.

AB - Gene modification of cells prior to their transplantation, especially stem cells, enhances their survival and increases their function in cell therapy. Like the Trojan horse, the gene-modified cell has to gain entrance inside the host's walls and survive and deliver its transgene products Using cellular, molecular and gene manipulation techniques the transplanted cell can be protected in a hostile environment from immune rejection, inflammation, hypoxia and apoptosis. Genetic engineering to modify cells involves constructing modules of functional gene sequences. They can be simple reporter genes or complex cassettes with gene switches, cell specific promoters and multiple transgenes. We discuss methods to deliver and construct gene cassettes with viral and non-viral delivery, siRNA, and conditional Cre/Lox P. We review the current uses of gene-modified stem cells in cardiovascular disease, diabetes, neurological diseases, (including Parkinson's, Alzheimer's and spinal cord injury repair), bone defects, hemophilia, and cancer.

KW - Cancer

KW - Cre/Lox P

KW - Diabetes

KW - Heart failure

KW - MicroRNA

KW - Neurological diseases

KW - Stem cells

KW - Vigilant Vector

UR - http://www.scopus.com/inward/record.url?scp=36849043025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849043025&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2007.08.035

DO - 10.1016/j.addr.2007.08.035

M3 - Review article

VL - 60

SP - 160

EP - 172

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 2

ER -